18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Tássia Machado MedeirosStephan AltmayerGuilherme WatteMatheus ZanonAdriano Basso DiasNatália Henz ConcattoJulia Hoefel PaesRita MattielloFrancisco de Souza SantosTan-Lucien MohammedNupur VermaBruno HochheggerPublished in: European radiology (2020)
• Whole-body MRI with or without diffusion-weighted imaging has a high accuracy for the diagnostic evaluation of metastases in patients with non-small cell lung cancer. • Whole-body MRI may be used as a non-invasive and radiation-free alternative to positron emission tomography with CT with similar diagnostic performance.